Orchid Pharma

Orchid Pharma Inks USD 80 Million Latin American Licensing Deal for Exblifep

Orchid Pharma enters a licensing deal with Laboratorio Libra for Exblifep in Latin America, representing a potential USD 80 million opportunity over 10 years.

Orchid Pharma · 24 Oct 2026, 5:06 PM IST